TEVA PHARMACEUTICAL INDUSTRIES LTD Common Stock, Par or Stated Value Per Share in USD/shares from Q4 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares, ILS/shares, and CHF/shares
Description
Face amount or stated value per share of common stock.
Summary
Teva Pharmaceutical Industries Ltd quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2017 to Q3 2025.
  • Teva Pharmaceutical Industries Ltd Common Stock, Par or Stated Value Per Share for the quarter ending September 30, 2025 was 0.1 USD/shares, unchanged year-over-year.
Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)

TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Common Stock, Par or Stated Value Per Share (USD/shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $0.10 $0 0% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $0.10 Jun 30, 2025 10-Q 2025-07-30
Q4 2024 $0.10 $0 0% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 $0.10 Sep 30, 2024 10-Q 2024-11-06
Q4 2023 $0.10 Dec 31, 2023 10-Q 2024-11-06
Q2 2022 $0.10 Jun 30, 2022 10-Q 2022-07-27
Q4 2021 $0.10 Dec 31, 2021 10-Q 2022-07-27
Q2 2018 $0.10 Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $0.10 Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $0.10 Dec 31, 2017 10-Q 2018-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.